Waters Corporation (WAT)
NYSE: WAT · Real-Time Price · USD
337.89
-2.81 (-0.82%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Waters Revenue
In the year 2024, Waters had annual revenue of $2.96B with 0.07% growth. Waters had revenue of $872.71M in the quarter ending December 31, 2024, with 6.50% growth.
Revenue (ttm)
$2.96B
Revenue Growth
+0.07%
P/S Ratio
6.78
Revenue / Employee
$389,261
Employees
7,600
Market Cap
20.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.96B | 1.97M | 0.07% |
| Dec 31, 2023 | 2.96B | -15.54M | -0.52% |
| Dec 31, 2022 | 2.97B | 186.08M | 6.68% |
| Dec 31, 2021 | 2.79B | 420.51M | 17.78% |
| Dec 31, 2020 | 2.37B | -41.23M | -1.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
WAT News
- 17 days ago - Waters Corporation Schedules First Quarter 2025 Earnings Conference Call - PRNewsWire
- 24 days ago - Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC - PRNewsWire
- 7 weeks ago - Waters Corporation to Present at the Leerink Partners Global Healthcare Conference - PRNewsWire
- 2 months ago - Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern - Seeking Alpha
- 2 months ago - Waters Corporation (WAT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 2 months ago - Waters ElectroForce Apex 1 Instrument Offers Increased Versatility, Simplicity, and Speed to Mechanical Testing of Advanced Polymer Materials - PRNewsWire
- 3 months ago - Weighing In On Waters Corporation: Facing A Valuation Headwind - Seeking Alpha